期刊文献+

人类心血管系统疾病干细胞模型的研究进展 被引量:1

Progress of stem cell models in human cardiovascular disease
下载PDF
导出
摘要 随着干细胞和人类遗传学研究的发展,患者特异细胞和组织模型已逐步进入到应用阶段。本文概述了在心血管疾病遗传模型方面利用多能干细胞的途径,包括ES细胞系的基因修饰,特异疾病iPS细胞的生成,先祖细胞的分离扩增等。以有效的方式利用这些干细胞模型,将推动疾病机理和药物治疗研究。 Along with the remarkable advances achieved in stem cell biology and human genetics research in the past few years, the patient-speci? c cells and tissue models step into application. This paper reviews the contribution of progenitor cells to cardiogenesis and clarifies how pluripotent stem cells can be applied in the modeling of cardiovascular disease, including gene modification of ES, generation of disease- specific iPS,isolation and amplification of progenitor cells. Utilizing these stem cell models in effective ways will have profound consequences for the research of disease mechanism and drug screening.
出处 《北京生物医学工程》 2014年第2期197-199,共3页 Beijing Biomedical Engineering
关键词 心血管疾病 模型 胚胎干细胞 诱导性多能干细胞 cardiovascular disease model embryonic stem cell induced pluripotent stem cell
  • 相关文献

参考文献1

二级参考文献15

  • 1Capecchi MR. Generating mice with targeted mutations. Nat Med 2001; 7:1086-1090.
  • 2te Riele H, Maandag ER, Clarke A, Hooper M, Berns A. Consecutive inactivation of both alleles of the pim-1 protooncogene by homologous recombination in embryonic stem cells. Nature 1990; 348:649-651.
  • 3Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AA, Seidman JG. Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol 1992; 12:2391- 2395.
  • 4Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol.2003; 21:319-321.
  • 5Thyagarajan B, Liu Y, Shin S, et al. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 2008; 26:119-126.
  • 6Lombardo A, Genovese P, Beausejour CM, et al Gene editing in human stem cells using zinc finger nucleases and integrasedefective lentiviral vector delivery. Nat Biotechnol 2007; 25:1298-1306.
  • 7Zou J, Maeder ML, Mali P, et al. Gene targeting of a diseaserelated gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009; 5:97-110.
  • 8Hockemeyer D, Soldner F, Beard C, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol.2009; 27:851-857.
  • 9Gao X, Tate P, Hu P, Tjian R, Skames WC, Wang Z. ES cell pluripotency and germ layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proe Natl dead Sei USA 2008; 105:6656-6661.
  • 10Friedel RH, Plump A, Lu X, et al. Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes. Proc Natl Acad Sci USA 2005; 102:13188-13193.

共引文献5

同被引文献16

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部